Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03453801 · ClinicalTrials.gov registry record · Phase 1
The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and Infection
A Phase 1 study of Healthy and Influenza, sponsored by Stanford University.
- Completed
- Registry status
- Phase 1
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT03453801: Completed Phase 1 study of Healthy and Influenza, sponsored by Stanford University.
NCT03453801 is a Phase 1 study of Healthy and Influenza that has completed, run by Stanford University. The registered enrollment target is 80 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03453801, a Phase 1 study of Healthy and Influenza, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is provide a better understanding of the adaptive immune response to the licensed influenza vaccines in children.
Primary Outcome
The percentage of cells with the various antigen-specific T memory phenotypes will be determined.
Interventions
- BIOLOGICAL Fluzone®
- BIOLOGICAL FluMist®
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2014-09-30 |
| Est. Completion | 2019-01-14 |
| Phase | Phase 1 |
What the finished NCT03453801 record still lists
NCT03453801 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (88% lower).
The record links to 2 conditions, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Fluzone® is the first listed.
NCT03453801 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03453801 about?
NCT03453801 is a clinical study titled "The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and Infection". The purpose of this study is provide a better understanding of the adaptive immune response to the licensed influenza vaccines in children.
What is the current status of trial NCT03453801?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 80 participants. The study started on 2014-09-30. Estimated completion is 2019-01-14.
What conditions does trial NCT03453801 study?
This clinical trial studies the following conditions: Healthy, Influenza.
What interventions are being tested in trial NCT03453801?
The interventions under investigation include: Fluzone® (BIOLOGICAL), FluMist® (BIOLOGICAL).
Who is sponsoring clinical trial NCT03453801?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03453801 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03453801's enrollment target sits among peer trials
80 274th of 1090 higher than 802 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
A Study of LY3867070 in Healthy Participants
RECRUITING · Phase 1
-
A Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of AZD1613 in Healthy Participants.
RECRUITING · Phase 1
-
Evaluate the Pharmacokinetics, Safety, and Tolerability of NSHO-101 in Healthy Participants
RECRUITING · Phase 1
-
Comparison of the Short-Term Effect of Dietary Carbohydrate Restriction Versus Exogenous Ketone Supplementation on Myocardial Glucose Suppression and Timing to Achieve a State of Ketosis Using FDG PET/CT Serial Imaging
RECRUITING · Phase 1
-
A Study of V118E in Healthy Participants (V118E-003)
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI